Top compounds associated with response to CTSE


Feature Type Standardized
Nominal ANOVA
mRNA BMS-708163 GDSC1000 pan-cancer AAC 0.15 2e-05
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.17 4e-05
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.13 0.0007
mRNA RDEA119 GDSC1000 pan-cancer AAC 0.099 0.002
mRNA niclosamide CTRPv2 pan-cancer AAC -0.12 0.002
mRNA PF-543 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.003
mRNA Erlotinib CCLE pan-cancer AAC 0.15 0.003
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.004
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.004
Download CSV